Our Partnership Model

Simple, Transparent, Aligned. The Welbeck partnership model ensures clarity, fairness, and long-term stability.

Two Linked Entities

Clinician Partners Group LLP

  • holds 49% ownership of the joint venture

  • oversees partner entry/exit, shareholding, distribution, and governance

  • manages allocation of investment and ongoing adjustments to shareholding based on contribution

Joint Venture Company (JVCo)

  • holds 51% ownership of the joint venture

  • oversees the CQC registration, insurer contracts, and staffing

  • manages daily operations, hiring, expenditure, marketing, and performance

  • governed by a board with equal representation from clinicians and Welbeck

Investment Structure

The model is designed to be tax-efficient, transparent, and aligned with regulatory guidance. Clinician investment is structured as a loan and equity model.

Advantages include:

  • early and predictable returns

  • tax-efficient distributions

  • increased consistency and security (loans are paid back before equity)

  • a transparent, regulated profit distribution framework

Partners may invest individually or through their limited company.

Governance

Welbeck’s governance model is one of the key differentiators, with 3 tiers. This ensures decisions are clinician-driven, aligned with best practice, and reflective of real-world service needs.

1. Joint Venture Company Board

  • equal representation

  • oversees strategy, operations, staffing, capital expenditure, marketing, and performance

  • no casting vote for Welbeck on operational matters

  • encourages collaborative decision-making

2. Clinician Partners Group LLP Board

  • 10 to 15 elected Partners

  • manages partnership membership, share distribution, and financial flows

  • oversees key approvals (new specialties, legal changes, major capital decisions)

3. Specialty Group Boards

  • manage their own membership, share allocation, and service design

  • oversee clinical pathways, guidelines, and group strategy